Priya S. Chockalingam

Company: Beam Therapeutics
Job title: Vice President, Head of Clinical Bioanalytics and Translational Sciences
Seminars:
Identifying the Role of Clinical Biomarkers in Genome Editing Therapeutics for Sickle Cell Disease 3:30 pm
• Biomarkers to support efficacy of gene editing therapies to treat sickle cell disease • Specialized biomarker discovery to assess disease pathophysiology • Importance and opportunity biomarkers bring to accelerate clinical developmentRead more
day: Day Two